Current multicentre studies with the excimer laser: design and aims.
Journal Article (Clinical Trial;Journal Article;Review)
Excimer laser ablation to remove atherosclerotic plaque has been used for over a decade as a methodology to treat cardiovascular disease. Improvements in the technique and technology of excimer laser angioplasty, coupled with the recognition of new clinical opportunities for this treatment modality, have resulted in a resurgence of interest in the laser. Three clinical trials are now being conducted to explore potential applications, including the LARS trial of excimer laser versus balloon angioplasty to treat in-stent restenosis, the PELA trial of excimer laser angioplasty in occluded superficial femoral artery disease, and the LACI trial of excimer laser angioplasty in limb-threatening ischaemia. This article describes the rationale and objectives of these new approaches to some of the more challenging problems in cardiovascular disease.
Full Text
Duke Authors
Cited Authors
- Tcheng, JE; Volkert-Noethen, AA
Published Date
- 2001
Published In
Volume / Issue
- 16 / 2
Start / End Page
- 122 - 129
PubMed ID
- 11484753
International Standard Serial Number (ISSN)
- 0268-8921
Digital Object Identifier (DOI)
- 10.1007/pl00011341
Language
- eng
Conference Location
- England